Calcium is a vital mineral that plays an integral role in various physiological processes, including bone metabolism. Understanding the role of calcium in maintaining skeletal health is crucial for healthcare professionals, as it impacts clinical decisions related to prevention and treatment of bone-related disorders.
Calcium is a primary component of hydroxyapatite, the mineral complex that provides rigidity to the skeletal system. It is indispensable for bone formation and remodeling, processes that maintain bone density and strength. The homeostasis of calcium is regulated by hormones such as parathyroid hormone (PTH), vitamin D, and calcitonin, which coordinate the absorption, excretion, and deposition of calcium in the bone.
A deficiency in calcium intake can lead to decreased bone mass, a condition known as osteopenia, and eventually to osteoporosis. These conditions are characterized by increased bone fragility and fracture risk. Regular monitoring of serum calcium levels and ensuring adequate dietary calcium intake is critical in preventing these bone disorders.
Calcium supplementation is a common strategy in the management of calcium deficiency. However, the efficacy of supplementation depends on various factors including the individual's age, gender, hormonal status, and comorbidities. Therefore, a personalized approach to calcium supplementation is essential for optimal bone health.
In conclusion, calcium plays a critical role in bone metabolism and overall skeletal health. As healthcare professionals, understanding the role of calcium in bone metabolism is essential for the prevention, diagnosis, and treatment of bone-related disorders. Therefore, regular monitoring of calcium levels, promoting adequate dietary intake, and personalized calcium supplementation are key strategies in maintaining bone health.
1.
Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars
2.
The Growing Role of AI in Cancer Treatment
3.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
4.
Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.
5.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
1.
Drug Exposure in Tumor Microenvironments: Mechanisms, Clinical Implications, and Emerging Strategies
2.
Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
3.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
4.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation